nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—liver cancer	0.468	1	CbGaD
Prasugrel—CYP2B6—Sorafenib—liver cancer	0.0963	0.306	CbGbCtD
Prasugrel—CYP2C19—Sorafenib—liver cancer	0.0612	0.195	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—liver cancer	0.0584	0.186	CbGbCtD
Prasugrel—CYP2C9—Sorafenib—liver cancer	0.0509	0.162	CbGbCtD
Prasugrel—CYP3A4—Sorafenib—liver cancer	0.0296	0.0941	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—liver cancer	0.018	0.0571	CbGbCtD
Prasugrel—Haematoma—Sorafenib—liver cancer	0.00388	0.0455	CcSEcCtD
Prasugrel—Neoplasm malignant—Sorafenib—liver cancer	0.00286	0.0335	CcSEcCtD
Prasugrel—Haematochezia—Epirubicin—liver cancer	0.00224	0.0262	CcSEcCtD
Prasugrel—Neoplasm—Sorafenib—liver cancer	0.00221	0.0258	CcSEcCtD
Prasugrel—Pericardial effusion—Epirubicin—liver cancer	0.0022	0.0258	CcSEcCtD
Prasugrel—Haematochezia—Doxorubicin—liver cancer	0.00207	0.0243	CcSEcCtD
Prasugrel—Pericardial effusion—Doxorubicin—liver cancer	0.00203	0.0238	CcSEcCtD
Prasugrel—Pain in extremity—Sorafenib—liver cancer	0.00177	0.0208	CcSEcCtD
Prasugrel—Gingival bleeding—Epirubicin—liver cancer	0.00159	0.0186	CcSEcCtD
Prasugrel—Gingival bleeding—Doxorubicin—liver cancer	0.00147	0.0172	CcSEcCtD
Prasugrel—Epistaxis—Sorafenib—liver cancer	0.00129	0.0151	CcSEcCtD
Prasugrel—Hyperlipidaemia—Epirubicin—liver cancer	0.00125	0.0147	CcSEcCtD
Prasugrel—Haemoglobin—Sorafenib—liver cancer	0.00123	0.0144	CcSEcCtD
Prasugrel—Haemorrhage—Sorafenib—liver cancer	0.00123	0.0144	CcSEcCtD
Prasugrel—Haemoptysis—Epirubicin—liver cancer	0.00122	0.0143	CcSEcCtD
Prasugrel—Urinary tract disorder—Sorafenib—liver cancer	0.00121	0.0142	CcSEcCtD
Prasugrel—Urethral disorder—Sorafenib—liver cancer	0.0012	0.0141	CcSEcCtD
Prasugrel—Hyperlipidaemia—Doxorubicin—liver cancer	0.00116	0.0136	CcSEcCtD
Prasugrel—Haemoptysis—Doxorubicin—liver cancer	0.00113	0.0132	CcSEcCtD
Prasugrel—Angiopathy—Sorafenib—liver cancer	0.00111	0.013	CcSEcCtD
Prasugrel—Immune system disorder—Sorafenib—liver cancer	0.00111	0.013	CcSEcCtD
Prasugrel—Mediastinal disorder—Sorafenib—liver cancer	0.0011	0.0129	CcSEcCtD
Prasugrel—Neoplasm malignant—Epirubicin—liver cancer	0.00106	0.0124	CcSEcCtD
Prasugrel—Rectal haemorrhage—Epirubicin—liver cancer	0.000999	0.0117	CcSEcCtD
Prasugrel—Anaemia—Sorafenib—liver cancer	0.000986	0.0116	CcSEcCtD
Prasugrel—Neoplasm malignant—Doxorubicin—liver cancer	0.000978	0.0114	CcSEcCtD
Prasugrel—Angioedema—Sorafenib—liver cancer	0.000975	0.0114	CcSEcCtD
Prasugrel—Leukopenia—Sorafenib—liver cancer	0.000955	0.0112	CcSEcCtD
Prasugrel—Cough—Sorafenib—liver cancer	0.000931	0.0109	CcSEcCtD
Prasugrel—Rectal haemorrhage—Doxorubicin—liver cancer	0.000924	0.0108	CcSEcCtD
Prasugrel—Hypertension—Sorafenib—liver cancer	0.000921	0.0108	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000902	0.0106	CcSEcCtD
Prasugrel—Anaphylactic shock—Sorafenib—liver cancer	0.000871	0.0102	CcSEcCtD
Prasugrel—Thrombocytopenia—Sorafenib—liver cancer	0.000853	0.00999	CcSEcCtD
Prasugrel—Skin disorder—Sorafenib—liver cancer	0.000846	0.00991	CcSEcCtD
Prasugrel—Neoplasm—Epirubicin—liver cancer	0.000816	0.00955	CcSEcCtD
Prasugrel—Ecchymosis—Epirubicin—liver cancer	0.000816	0.00955	CcSEcCtD
Prasugrel—Dyspnoea—Sorafenib—liver cancer	0.000776	0.00909	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—liver cancer	0.000755	0.00884	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—liver cancer	0.000755	0.00884	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Sorafenib—liver cancer	0.000752	0.00881	CcSEcCtD
Prasugrel—Fatigue—Sorafenib—liver cancer	0.000751	0.00879	CcSEcCtD
Prasugrel—Body temperature increased—Sorafenib—liver cancer	0.000688	0.00806	CcSEcCtD
Prasugrel—Cerebrovascular accident—Epirubicin—liver cancer	0.000668	0.00783	CcSEcCtD
Prasugrel—Pain in extremity—Epirubicin—liver cancer	0.000655	0.00767	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000655	0.00767	CcSEcCtD
Prasugrel—Hypersensitivity—Sorafenib—liver cancer	0.000642	0.00751	CcSEcCtD
Prasugrel—Asthenia—Sorafenib—liver cancer	0.000625	0.00732	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—liver cancer	0.000618	0.00724	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—liver cancer	0.000606	0.0071	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000606	0.0071	CcSEcCtD
Prasugrel—Diarrhoea—Sorafenib—liver cancer	0.000596	0.00698	CcSEcCtD
Prasugrel—Dizziness—Sorafenib—liver cancer	0.000576	0.00674	CcSEcCtD
Prasugrel—Rash—Sorafenib—liver cancer	0.000549	0.00643	CcSEcCtD
Prasugrel—Dermatitis—Sorafenib—liver cancer	0.000549	0.00643	CcSEcCtD
Prasugrel—Headache—Sorafenib—liver cancer	0.000546	0.00639	CcSEcCtD
Prasugrel—Nausea—Sorafenib—liver cancer	0.000517	0.00606	CcSEcCtD
Prasugrel—Haematuria—Epirubicin—liver cancer	0.000481	0.00564	CcSEcCtD
Prasugrel—Epistaxis—Epirubicin—liver cancer	0.000476	0.00557	CcSEcCtD
Prasugrel—Bradycardia—Epirubicin—liver cancer	0.000461	0.0054	CcSEcCtD
Prasugrel—Haemoglobin—Epirubicin—liver cancer	0.000455	0.00533	CcSEcCtD
Prasugrel—Haemorrhage—Epirubicin—liver cancer	0.000453	0.00531	CcSEcCtD
Prasugrel—Urinary tract disorder—Epirubicin—liver cancer	0.000447	0.00524	CcSEcCtD
Prasugrel—Oedema peripheral—Epirubicin—liver cancer	0.000446	0.00523	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—liver cancer	0.000445	0.00521	CcSEcCtD
Prasugrel—Urethral disorder—Epirubicin—liver cancer	0.000444	0.0052	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—liver cancer	0.00044	0.00516	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—liver cancer	0.000427	0.005	CcSEcCtD
Prasugrel—Eye disorder—Epirubicin—liver cancer	0.000423	0.00496	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—liver cancer	0.000421	0.00493	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—liver cancer	0.000419	0.00491	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—liver cancer	0.000414	0.00485	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—liver cancer	0.000413	0.00484	CcSEcCtD
Prasugrel—Angiopathy—Epirubicin—liver cancer	0.000411	0.00481	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—liver cancer	0.000411	0.00481	CcSEcCtD
Prasugrel—Immune system disorder—Epirubicin—liver cancer	0.000409	0.00479	CcSEcCtD
Prasugrel—Mediastinal disorder—Epirubicin—liver cancer	0.000408	0.00478	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—liver cancer	0.000392	0.00459	CcSEcCtD
Prasugrel—Back pain—Epirubicin—liver cancer	0.000381	0.00447	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—liver cancer	0.00038	0.00445	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—liver cancer	0.000379	0.00443	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—liver cancer	0.000378	0.00442	CcSEcCtD
Prasugrel—Anaemia—Epirubicin—liver cancer	0.000365	0.00427	CcSEcCtD
Prasugrel—Leukopenia—Epirubicin—liver cancer	0.000353	0.00413	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—liver cancer	0.000353	0.00413	CcSEcCtD
Prasugrel—Cough—Epirubicin—liver cancer	0.000344	0.00403	CcSEcCtD
Prasugrel—Hypertension—Epirubicin—liver cancer	0.00034	0.00399	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—liver cancer	0.000337	0.00395	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000333	0.00391	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—liver cancer	0.000327	0.00383	CcSEcCtD
Prasugrel—Anaphylactic shock—Epirubicin—liver cancer	0.000322	0.00377	CcSEcCtD
Prasugrel—Cough—Doxorubicin—liver cancer	0.000318	0.00373	CcSEcCtD
Prasugrel—Thrombocytopenia—Epirubicin—liver cancer	0.000315	0.00369	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—liver cancer	0.000315	0.00369	CcSEcCtD
Prasugrel—Skin disorder—Epirubicin—liver cancer	0.000313	0.00366	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000309	0.00361	CcSEcCtD
Prasugrel—Hypotension—Epirubicin—liver cancer	0.000301	0.00352	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—liver cancer	0.000298	0.00349	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—liver cancer	0.000292	0.00341	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—liver cancer	0.000289	0.00339	CcSEcCtD
Prasugrel—Dyspnoea—Epirubicin—liver cancer	0.000287	0.00336	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—liver cancer	0.000278	0.00326	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Epirubicin—liver cancer	0.000278	0.00325	CcSEcCtD
Prasugrel—Fatigue—Epirubicin—liver cancer	0.000277	0.00325	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—liver cancer	0.000266	0.00311	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000257	0.00301	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—liver cancer	0.000257	0.00301	CcSEcCtD
Prasugrel—Body temperature increased—Epirubicin—liver cancer	0.000254	0.00298	CcSEcCtD
Prasugrel—Hypersensitivity—Epirubicin—liver cancer	0.000237	0.00278	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—liver cancer	0.000235	0.00276	CcSEcCtD
Prasugrel—Asthenia—Epirubicin—liver cancer	0.000231	0.0027	CcSEcCtD
Prasugrel—Diarrhoea—Epirubicin—liver cancer	0.00022	0.00258	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—liver cancer	0.000219	0.00257	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—liver cancer	0.000214	0.0025	CcSEcCtD
Prasugrel—Dizziness—Epirubicin—liver cancer	0.000213	0.00249	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—liver cancer	0.000204	0.00239	CcSEcCtD
Prasugrel—Rash—Epirubicin—liver cancer	0.000203	0.00238	CcSEcCtD
Prasugrel—Dermatitis—Epirubicin—liver cancer	0.000203	0.00237	CcSEcCtD
Prasugrel—Headache—Epirubicin—liver cancer	0.000202	0.00236	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—liver cancer	0.000197	0.00231	CcSEcCtD
Prasugrel—Nausea—Epirubicin—liver cancer	0.000191	0.00224	CcSEcCtD
Prasugrel—Rash—Doxorubicin—liver cancer	0.000188	0.0022	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—liver cancer	0.000188	0.0022	CcSEcCtD
Prasugrel—Headache—Doxorubicin—liver cancer	0.000187	0.00219	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—liver cancer	0.000177	0.00207	CcSEcCtD
Prasugrel—CYP2B6—Metabolism—GSTA3—liver cancer	4.73e-05	0.000358	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—AKT1—liver cancer	4.71e-05	0.000357	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	4.66e-05	0.000353	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PRKCE—liver cancer	4.61e-05	0.000349	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	4.55e-05	0.000345	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.55e-05	0.000345	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KDR—liver cancer	4.54e-05	0.000344	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK14—liver cancer	4.51e-05	0.000342	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ESR1—liver cancer	4.42e-05	0.000335	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	4.41e-05	0.000334	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ABL1—liver cancer	4.39e-05	0.000332	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—F2—liver cancer	4.37e-05	0.000331	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IGF2—liver cancer	4.37e-05	0.000331	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTA4—liver cancer	4.33e-05	0.000328	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTA2—liver cancer	4.22e-05	0.000319	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CPT1B—liver cancer	4.2e-05	0.000318	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GLUL—liver cancer	4.2e-05	0.000318	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APC—liver cancer	4.18e-05	0.000317	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CG—liver cancer	4.18e-05	0.000317	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	4.18e-05	0.000317	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HGF—liver cancer	4.12e-05	0.000313	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.08e-05	0.000309	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CSF2—liver cancer	4.08e-05	0.000309	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTA1—liver cancer	4.07e-05	0.000308	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NR1H4—liver cancer	4.05e-05	0.000307	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NAT2—liver cancer	4.02e-05	0.000305	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTA3—liver cancer	3.98e-05	0.000302	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BRAF—liver cancer	3.93e-05	0.000298	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALDOB—liver cancer	3.86e-05	0.000292	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	3.83e-05	0.00029	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GLUL—liver cancer	3.77e-05	0.000286	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CPT1B—liver cancer	3.77e-05	0.000286	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UGDH—liver cancer	3.74e-05	0.000284	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.72e-05	0.000282	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CRABP1—liver cancer	3.68e-05	0.000279	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CD—liver cancer	3.68e-05	0.000279	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—liver cancer	3.64e-05	0.000276	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTA4—liver cancer	3.64e-05	0.000276	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SERPINE1—liver cancer	3.64e-05	0.000276	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NR1H4—liver cancer	3.64e-05	0.000276	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—KRAS—liver cancer	3.6e-05	0.000273	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTA3—liver cancer	3.57e-05	0.000271	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.56e-05	0.00027	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.55e-05	0.000269	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTA2—liver cancer	3.55e-05	0.000269	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—EPT1—liver cancer	3.52e-05	0.000267	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GLUL—liver cancer	3.44e-05	0.000261	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CPT1B—liver cancer	3.44e-05	0.000261	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTA1—liver cancer	3.42e-05	0.000259	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NAT2—liver cancer	3.39e-05	0.000257	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TAT—liver cancer	3.34e-05	0.000253	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NR1H4—liver cancer	3.31e-05	0.000251	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—liver cancer	3.31e-05	0.000251	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK14—liver cancer	3.3e-05	0.00025	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RAF1—liver cancer	3.28e-05	0.000249	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTA4—liver cancer	3.27e-05	0.000248	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	3.26e-05	0.000247	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA3—liver cancer	3.26e-05	0.000247	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.26e-05	0.000247	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALDOB—liver cancer	3.25e-05	0.000246	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HPGDS—liver cancer	3.21e-05	0.000244	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MTOR—liver cancer	3.2e-05	0.000243	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CB—liver cancer	3.2e-05	0.000243	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—F2—liver cancer	3.2e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.19e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTA2—liver cancer	3.19e-05	0.000241	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CRABP1—liver cancer	3.1e-05	0.000235	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	3.1e-05	0.000235	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTA1—liver cancer	3.07e-05	0.000233	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—liver cancer	3.06e-05	0.000232	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—HRAS—liver cancer	3.06e-05	0.000232	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NAT2—liver cancer	3.04e-05	0.00023	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1B—liver cancer	3.01e-05	0.000228	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA4—liver cancer	2.98e-05	0.000226	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—liver cancer	2.97e-05	0.000225	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CASP3—liver cancer	2.95e-05	0.000223	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—liver cancer	2.94e-05	0.000223	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—liver cancer	2.93e-05	0.000222	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.92e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDOB—liver cancer	2.91e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.91e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA2—liver cancer	2.9e-05	0.00022	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—liver cancer	2.87e-05	0.000217	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSMD10—liver cancer	2.87e-05	0.000217	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSMA4—liver cancer	2.87e-05	0.000217	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JUN—liver cancer	2.86e-05	0.000217	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNB1—liver cancer	2.84e-05	0.000215	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTA1—liver cancer	2.8e-05	0.000212	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.79e-05	0.000211	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GOT2—liver cancer	2.79e-05	0.000211	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—liver cancer	2.79e-05	0.000211	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CRABP1—liver cancer	2.78e-05	0.000211	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1A—liver cancer	2.78e-05	0.00021	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.77e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NAT2—liver cancer	2.77e-05	0.00021	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK8—liver cancer	2.71e-05	0.000205	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HPGDS—liver cancer	2.71e-05	0.000205	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—liver cancer	2.7e-05	0.000205	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CD—liver cancer	2.69e-05	0.000204	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.69e-05	0.000204	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.66e-05	0.000202	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SERPINE1—liver cancer	2.66e-05	0.000202	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDOB—liver cancer	2.66e-05	0.000201	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2E1—liver cancer	2.62e-05	0.000199	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CRABP1—liver cancer	2.53e-05	0.000192	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.5e-05	0.00019	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—liver cancer	2.5e-05	0.00019	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—liver cancer	2.48e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYCS—liver cancer	2.45e-05	0.000186	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.45e-05	0.000186	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HPGDS—liver cancer	2.43e-05	0.000184	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.42e-05	0.000183	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMA4—liver cancer	2.41e-05	0.000183	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMD10—liver cancer	2.41e-05	0.000183	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GOT1—liver cancer	2.41e-05	0.000182	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GGT1—liver cancer	2.41e-05	0.000182	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAF1—liver cancer	2.4e-05	0.000182	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GOT2—liver cancer	2.35e-05	0.000178	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CB—liver cancer	2.35e-05	0.000178	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—liver cancer	2.3e-05	0.000174	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—liver cancer	2.3e-05	0.000174	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.28e-05	0.000173	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CPT1B—liver cancer	2.27e-05	0.000172	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GLUL—liver cancer	2.27e-05	0.000172	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.27e-05	0.000172	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HPGDS—liver cancer	2.22e-05	0.000168	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2E1—liver cancer	2.21e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.2e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.2e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NR1H4—liver cancer	2.19e-05	0.000166	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.17e-05	0.000165	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMA4—liver cancer	2.17e-05	0.000164	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMD10—liver cancer	2.17e-05	0.000164	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—liver cancer	2.16e-05	0.000164	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—liver cancer	2.15e-05	0.000163	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA3—liver cancer	2.15e-05	0.000163	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.14e-05	0.000162	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—liver cancer	2.13e-05	0.000162	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—liver cancer	2.13e-05	0.000161	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GOT2—liver cancer	2.11e-05	0.00016	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.08e-05	0.000158	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYCS—liver cancer	2.06e-05	0.000156	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GGT1—liver cancer	2.03e-05	0.000154	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GOT1—liver cancer	2.03e-05	0.000154	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.01e-05	0.000152	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—liver cancer	1.99e-05	0.000151	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2E1—liver cancer	1.98e-05	0.00015	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.98e-05	0.00015	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMD10—liver cancer	1.97e-05	0.00015	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMA4—liver cancer	1.97e-05	0.00015	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA4—liver cancer	1.97e-05	0.000149	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—liver cancer	1.95e-05	0.000148	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GOT2—liver cancer	1.92e-05	0.000146	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.92e-05	0.000145	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA2—liver cancer	1.92e-05	0.000145	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—liver cancer	1.89e-05	0.000143	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A1—liver cancer	1.88e-05	0.000143	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYCS—liver cancer	1.85e-05	0.00014	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA1—liver cancer	1.85e-05	0.00014	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—liver cancer	1.83e-05	0.000139	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NAT2—liver cancer	1.83e-05	0.000138	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—liver cancer	1.82e-05	0.000138	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GGT1—liver cancer	1.82e-05	0.000138	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GOT1—liver cancer	1.82e-05	0.000138	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—liver cancer	1.81e-05	0.000137	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2E1—liver cancer	1.81e-05	0.000137	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—liver cancer	1.79e-05	0.000136	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MTHFR—liver cancer	1.76e-05	0.000133	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDOB—liver cancer	1.75e-05	0.000133	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.75e-05	0.000133	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—liver cancer	1.73e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARA—liver cancer	1.72e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYCS—liver cancer	1.69e-05	0.000128	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—liver cancer	1.68e-05	0.000127	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—liver cancer	1.67e-05	0.000127	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CRABP1—liver cancer	1.67e-05	0.000127	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GGT1—liver cancer	1.66e-05	0.000126	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GOT1—liver cancer	1.66e-05	0.000126	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—liver cancer	1.63e-05	0.000124	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—liver cancer	1.61e-05	0.000122	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—liver cancer	1.6e-05	0.000121	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A1—liver cancer	1.58e-05	0.00012	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—liver cancer	1.56e-05	0.000118	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—liver cancer	1.5e-05	0.000114	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—liver cancer	1.49e-05	0.000113	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MTHFR—liver cancer	1.48e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—liver cancer	1.47e-05	0.000112	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—liver cancer	1.47e-05	0.000111	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HPGDS—liver cancer	1.46e-05	0.000111	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARA—liver cancer	1.45e-05	0.00011	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—liver cancer	1.43e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—liver cancer	1.42e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A1—liver cancer	1.42e-05	0.000108	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—liver cancer	1.38e-05	0.000105	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—liver cancer	1.37e-05	0.000104	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTHFR—liver cancer	1.33e-05	0.000101	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—liver cancer	1.32e-05	0.0001	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.3e-05	9.87e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMD10—liver cancer	1.3e-05	9.87e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMA4—liver cancer	1.3e-05	9.87e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARA—liver cancer	1.3e-05	9.86e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A1—liver cancer	1.3e-05	9.83e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—liver cancer	1.3e-05	9.83e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—liver cancer	1.28e-05	9.7e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GOT2—liver cancer	1.27e-05	9.6e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—liver cancer	1.24e-05	9.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTHFR—liver cancer	1.21e-05	9.17e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—liver cancer	1.2e-05	9.08e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2E1—liver cancer	1.19e-05	9.03e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARA—liver cancer	1.19e-05	8.99e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.17e-05	8.86e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—liver cancer	1.17e-05	8.86e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—liver cancer	1.13e-05	8.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—liver cancer	1.11e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYCS—liver cancer	1.11e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GGT1—liver cancer	1.09e-05	8.29e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GOT1—liver cancer	1.09e-05	8.29e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—liver cancer	1.09e-05	8.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—liver cancer	1.08e-05	8.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.07e-05	8.08e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—liver cancer	1.02e-05	7.7e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—liver cancer	9.82e-06	7.44e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—liver cancer	9.81e-06	7.43e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—liver cancer	9.8e-06	7.43e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—liver cancer	9.69e-06	7.34e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—liver cancer	9.67e-06	7.33e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—liver cancer	9.51e-06	7.21e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—liver cancer	9.03e-06	6.84e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—liver cancer	8.93e-06	6.77e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—liver cancer	8.82e-06	6.68e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A1—liver cancer	8.56e-06	6.48e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—liver cancer	8.54e-06	6.47e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTHFR—liver cancer	7.98e-06	6.05e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARA—liver cancer	7.83e-06	5.93e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—liver cancer	7.79e-06	5.9e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—liver cancer	6.89e-06	5.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—liver cancer	6.7e-06	5.08e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—liver cancer	6.47e-06	4.9e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—liver cancer	5.89e-06	4.47e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—liver cancer	5.82e-06	4.41e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—liver cancer	5.8e-06	4.4e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—liver cancer	5.63e-06	4.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—liver cancer	5.21e-06	3.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—liver cancer	5.14e-06	3.89e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—liver cancer	4.75e-06	3.6e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—liver cancer	4.74e-06	3.59e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—liver cancer	4.25e-06	3.22e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—liver cancer	3.88e-06	2.94e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—liver cancer	3.13e-06	2.37e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—liver cancer	2.56e-06	1.94e-05	CbGpPWpGaD
